NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-091-2002-0-US-05 Zap70 Expression As A Marker for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) US DIV 13/155,198 8748114 Expired PDF
NIEHS E-009-2009-0-US-05 Inhibition Of Inter-Alpha-Trypsin Inhibitor For The Treatment of Airway Disease US National Stage 13/133,000 Abandoned
NCI E-200-2011-3-US-02 METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE US CIP 13/153,291 Abandoned
NIA E-189-2003-0-US-14 Thalidomide Analogs US DIV 13/153,355 8546430 Abandoned PDF
NCI E-132-2006-2-US-03 Materials And Methods Directed To Asparagine Synthetase And Asparaginase Therapies US DIV 13/151,420 9181552 Abandoned PDF
NIAID E-055-2009-0-US-03 Use Of The ROCK Inhibitor to Sustain Primary Human Keratinocytes In A Proliferative State US National Stage 13/132,391 8637310 Issued PDF
NCI E-048-1997-0-US-30 Methods of Gene Therapy Using NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER US CON 13/151,375 Abandoned
NCI E-170-2010-0-US-04 LINKED PURINE PTERIN HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS US National Stage 13/704,857 9029344 Abandoned PDF
NCI E-170-2010-0-EP-03 Linked Purine Pterin HPPK Inhibitors Useful As Antibacterial Agents EP National Stage 11796158.1 Abandoned
NCI E-170-2010-0-PCT-02 Linked Purine Pterin HPPK Inhibitors Useful As Antibacterial Agents PCT PCT COMB PCT/US2011/038744 Expired
CC E-036-2009-0-US-03 A Feedback System For Integrating Interventional Planning And Navigation US National Stage 13/131,886 9144461 Issued PDF
NIAID E-252-2012-0-US-01 Kunitz Inhibitor Of Proteases US 61/490,149 Abandoned
NIAID E-154-2011-0-US-01 Method for Inducing An Immune Response Against Avian, Swine, H1N1, H5N1 Influenza Viruses And Formulations Thereof US 61/490,050 Abandoned
NCI E-293-2010-0-US-01 Lipopeptide Inhibitors Of RAS Oncoprotein US 61/489,919 Abandoned
NIAID E-154-2011-1-US-01 Immune Based Treatment For Influenza US 61/490,056 Abandoned
NCI E-082-2014-0-US-01 ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS US 61/489,900 Expired
NCI E-021-2001-0-US-11 Chromosome 3p21.3 Genes Are Tumor Suppressors US CON 13/114,921 9944951 Expired PDF
NIDCR E-015-2002-3-JP-09 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS JP DIV 2008-260180 Abandoned
NINDS E-206-2011-0-US-01 Use Of Phosphatase Inhibitors or Histone Deacetylase Inhibitors To Treat Gaucher's Disease US 61/489,469 Abandoned
NCI E-215-2008-0-US-05 Gene Expression Signature Of Genomic Instability In Breast Cancer US National Stage 13/119,101 8741574 Abandoned PDF
CC E-063-2006-0-US-02 Hybrid Segmentation Of Anatomical Structure US CON 13/113,849 8340381 Issued PDF
NIAID E-186-2011-0-US-01 Prime-boost Vaccine Strategies Incorporating Lymphocytic Choriomeningitis Virus (LCMV) Vaccines To Protect Against Lentiviral Infection US 61/489,205 Abandoned
NCI E-103-2010-1-EP-02 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins EP National Stage 11722270.3 Issued
NCI E-103-2010-1-GB-07 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins GB EP 11722270.3 Issued
NCI E-103-2010-1-DE-05 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins DE EP 11722270.3 Issued
NCI E-103-2010-1-FR-06 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins FR EP 11722270.3 Issued
NCI E-103-2010-1-PCT-01 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins PCT PCT COMB PCT/US2011/037439 Expired
NIEHS E-298-1999-1-US-06 Inhibitors of Epoxide Hydrolase For The Treatment of Hypertension US CON 13/113,028 Abandoned
NIAMS E-073-2011-0-US-01 Blockade of TL1A-DR3 Interactions To Ameliorate T Cell Mediated Disease Pathology And Antibodies Thereof US 61/488,671 Abandoned
NIDA E-221-2010-0-PCT-02 Phenylmorpholines And Analogues Thereof PCT PCT PCT/US11/037361 Expired
NCI E-188-2004-0-US-08 Nitric Oxide-Releasing Diazeniumdiolated Compounds US DIV 13/111,613 8093343 Abandoned PDF
NIAID E-125-2008-0-US-03 Monoclonal Antibodies That React With The Capsule Of Bacillus Anthracis US National Stage 13/130,044 8501182 Abandoned PDF
NCATS E-134-2010-0-JP-06 Inhibitors of human 12-Lipoxygenase JP National Stage 511332/2013 Abandoned
NCATS E-134-2010-0-PCT-02 Inhibitors of human 12-Lipoxygenase PCT PCT PCT/US11/37000 Expired
NCATS E-134-2010-0-AU-03 Inhibitors of human 12-Lipoxygenase AU National Stage 2011255627 Abandoned
NCATS E-134-2010-0-CA-04 Inhibitors of human 12-Lipoxygenase CA National Stage 2799792 Abandoned
NCI E-203-2011-1-CN-04 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers CN National Stage 201180024535.7 Abandoned
NIDA E-176-2008-0-US-03 Differentiation Of Stem Cells Into Dopaminergic Cells US National Stage 13/129,661 8628962 Abandoned PDF
NCI E-203-2011-1-EP-03 INDENOQUINOLONE COMPOUND, PREPARATION METHOD AND USE THEREOF EP National Stage 11782937.4 Abandoned
NCI E-203-2011-0-CN-01 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers CN ORD 201010176288.X Abandoned
NCI E-203-2011-1-PCT-01 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers PCT PCT COMB PCT/CN11/074203 Expired
NIAID E-050-1997-1-US-16 Method For Detecting The Presence of a Single Target Nucleic Acid in a Sample US CON 13/108,959 8257925 Expired PDF
CC E-184-2011-0-US-01 Embolization Assistant System and Methods for Using the Same US 61/486,722 Abandoned
NIAID E-134-2011-0-US-01 Modified HIV Mosaic Envelopes Targeted To Elicit B Cell Responses US 61/486,495 Abandoned
NIA E-084-2011-1-US-01 Compositions and Methods For Increasing The Frequency Of Homologous Recombination US 61/486,017 Abandoned
NIA E-103-2011-0-US-01 Use of Zscan4 for Direct Reprogramming of Somatic Cells US 61/486,004 Abandoned
NIDDK E-129-2010-0-EP-03 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands EP National Stage 11721899.0 Issued
NCI E-167-2010-0-EP-03 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling EP National Stage 11720697.9 Issued
NCI E-167-2010-0-DE-05 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling DE EP 11720697.9 Issued
NCI E-167-2010-0-FR-07 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling FR EP 11720697.9 Issued